Efficacy and Safety of Adalimumab and Infliximab for Noninfectious Uveitis.,Ophthalmology

当前位置： X-MOL 学术 › Ophthalmology › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Efficacy and Safety of Adalimumab and Infliximab for Noninfectious Uveitis.
Ophthalmology ( IF 13.1 ) Pub Date : 2021-10-08 , DOI: 10.1016/j.ophtha.2021.09.025
Felicia Tai ₁ , Parsa Mehraban Far ₂ , Petros Pechlivanoglou ₃ , Lauren C Ramsay ₄ , Jorge R Georgakopoulos ₅ , Beate Sander ₆ , Larissa A Derzko-Dzulynsky ₇ , Tina Felfeli ₈

Affiliation

Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
Department of Ophthalmology, Kingston Health Sciences Center, Queen's University, Kingston, Canada.
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Canada; Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada.
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Public Health Ontario, Toronto, Canada; ICES, Toronto, Canada.
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada; Department of Ophthalmology, St. Joseph's Health Centre, Unity Health Toronto, Toronto, Canada; Department of Ophthalmology, St. Michael's Hospital, Unity Health Toronto, Toronto, Canada.
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.